Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT UBC Medical Indonesia TbkISX:LABS +0.68% 9-Day RSI is 54.18 as of Jul. 28, 2026. The stock has 2 warning signs investors should review. Among 864 Medical Devices & Instruments companies, PT UBC Medical Indonesia Tbk ranks worse than 74.19% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
ISX:LABS's 9-Day RSI is ranked worse than 74.19% of 864
companies
in the Medical Devices & Instruments industry
Industry Median: 43.115
vs ISX:LABS: 54.18
PT UBC Medical Indonesia Tbk (ISX:LABS) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
PT UBC Medical Indonesia Tbk 9-Day RSI Related Terms
ISX:LABS vs ABT, SYK, MDT: 9-Day RSI Comparison
For the Medical Devices subindustry, PT UBC Medical Indonesia Tbk's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT UBC Medical Indonesia Tbk 9-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PT UBC Medical Indonesia Tbk's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where PT UBC Medical Indonesia Tbk's 9-Day RSI falls into.
PT UBC Medical Indonesia Tbk (ISX:LABS) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT UBC Medical Indonesia Tbk (ISX:LABS) has a 9-Day RSI of 54.18 as of Jul. 28, 2026. According to the industry distribution chart, PT UBC Medical Indonesia Tbk ranks #641 out of 864 companies in the Medical Devices & Instruments industry, placing it in the top 74.2%.
Is PT UBC Medical Indonesia Tbk's 9-Day RSI too high?
PT UBC Medical Indonesia Tbk's current 9-Day RSI is 54.18. The Medical Devices & Instruments industry median 9-Day RSI is 43.12. PT UBC Medical Indonesia Tbk's value of 54.18 is 25.7% above this industry median. Based on the distribution chart, PT UBC Medical Indonesia Tbk ranks #641 out of 864 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does PT UBC Medical Indonesia Tbk's 9-Day RSI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, PT UBC Medical Indonesia Tbk ranks #641 out of 864 companies for 9-Day RSI. This places PT UBC Medical Indonesia Tbk in the lower half of its industry. The industry median 9-Day RSI is 43.12. PT UBC Medical Indonesia Tbk's value of 54.18 is 25.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Devices & Instruments company?
The median 9-Day RSI among Medical Devices & Instruments companies is 43.12, based on 864 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT UBC Medical Indonesia Tbk's current 9-Day RSI of 54.18 is 25.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median 9-Day RSI is 43.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT UBC Medical Indonesia Tbk's current 9-Day RSI is 54.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT UBC Medical Indonesia Tbk stock overvalued right now?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a current 9-Day RSI of 54.18. The current 9-Day RSI is 54.18 and 25.7% above the Medical Devices & Instruments industry median of 43.12. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For PT UBC Medical Indonesia Tbk (ISX:LABS), the current 9-Day RSI is 54.18 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT UBC Medical Indonesia Tbk is a distribution company. It engages in wholesale of Laboratory Equipment, Pharmaceutical Equipment, and Medical Equipment for Humans and animals, which includes the wholesale of laboratory equipment, pharmaceutical equipment, and medical equipment. It divides its main marketed medical equipment products into two categories Instruments, in the form of equipment, machines, and analyzers, are used in laboratories. The function of instruments is to process specimens or biological samples to measure and examine the levels of certain substances/contents; and Consumables include single-use medical devices used for treatment or health examinations and Reagents include chemical reagents used in laboratory tests to detect, measure, examine, & produce other substances.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:LABS has been successfully added to your 
